This is a $545,339.00 Definitive Contract awarded by the Food and Drug Administration (FDA) to Drexel University, a private research university located in Philadelphia, Pennsylvania. The contract was awarded under a Broad Agency Announcement (BAA) with the purpose of "DEVELOPING TOOLS BASED ON TEXT ANALYSIS AND MACHINE LEARNING TO ENHANCE PSG REVIEW EFFICIENCY". The contract is a Cost No Fee arrangement with a final completion date of September 29, 2023. Drexel University is known for its expertise across various disciplines, including engineering, biomedical sciences, and information technology, which it leverages to conduct research and develop new technologies for the U.S. government. This contract award is not designated as a set-aside and represents Drexel's ongoing relationship with federal agencies, particularly the Department of Defense, in providing educational and research services.
Generated 10/31/24, 9:02 AM